Brief: Biocartis Sees Negative 2023 EBITDA Of Between -25 And -28 Million Euros

Biocartis NV

23/02/2023 06:52

Feb 23 (Reuters) - Biocartis Group NV  BCART.BR :
    * FY TOTAL OPERATING INCOME OF EUR 58M (2021: EUR 54.9)
    * OUTLOOK 2023: PRODUCT RELATED REVENUES OF BETWEEN EUR 55M
AND
EUR 60M
    * OUTLOOK 2023: A GROSS MARGIN ON PRODUCT SALES OF BETWEEN
40% AND
45%
    * FY PRODUCT REVENUE OF EUR 45M (2021: EUR 40.5M), OF WHICH
EUR
35.9M FROM 334K CARTRIDGES SOLD AND EUR 9.2M FROM INSTRUMENT
RENTALS AND SALES
    * WE ARE CONFIDENT THAT IN 2023 WE WILL CONTINUE TO GROW
PRODUCT
RELATED REVENUES, AGAIN IMPROVE THE GROSS MARGIN ON PRODUCT
SALES AND FURTHER REDUCE THE OPERATING CASH BURN
    * OUTLOOK 2023: EBITDA OF BETWEEN EUR -25M AND EUR -28M
    * END-FY OPERATING CASH BURN OF EUR -38.5M, A REDUCTION OF
MORE
THAN A THIRD OR EUR 18.1M LOWER THAN IN 2021
    * FY GROSS PROFIT OF EUR 45 MILLION
    * FY NET LOSS EUR 47.7 MILLION VERSUS LOSS EUR 71.4 MILLION
YEAR
AGO
    * FY TOTAL OPERATING LOSS EUR 47.0 MILLION VERSUS LOSS EUR
62.6
MILLION YEAR AGO

Source text for Eikon: [ID: nGNE7vf0py]
Further company coverage:  BCART.BR 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))